Takeda Pharmaceutical Co (Takeda Pharmaceutical Co) Other Stockholders Equity : $16,749 Mil (As of Mar. 2024)

View and export this data going back to 2010. Start your Free Trial

What is Takeda Pharmaceutical Co Other Stockholders Equity?

Takeda Pharmaceutical Co's Other Stockholders Equity for the quarter that ended in Mar. 2024 was $16,749 Mil.

Takeda Pharmaceutical Co's quarterly Other Stockholders Equity declined from Sep. 2023 ($15,475 Mil) to Dec. 2023 ($13,819 Mil) but then increased from Dec. 2023 ($13,819 Mil) to Mar. 2024 ($16,749 Mil).

Takeda Pharmaceutical Co's annual Other Stockholders Equity increased from Mar. 2022 ($7,878 Mil) to Mar. 2023 ($11,283 Mil) and increased from Mar. 2023 ($11,283 Mil) to Mar. 2024 ($16,749 Mil).

Takeda Pharmaceutical Co Other Stockholders Equity Historical Data

The historical data trend for Takeda Pharmaceutical Co's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Takeda Pharmaceutical Co Other Stockholders Equity Chart

Takeda Pharmaceutical Co Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Other Stockholders Equity

Get a 7-Day Free Trial

859.72

3,368.14

7,878.18

11,282.88

16,748.99

Takeda Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Stockholders Equity	Get a 7-Day Free Trial															11,282.88	14,946.88	15,475.45	13,818.91	16,748.99

Takeda Pharmaceutical Co Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

Takeda Pharmaceutical Co Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Takeda Pharmaceutical Co's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Takeda Pharmaceutical Co (Takeda Pharmaceutical Co) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Takeda Pharmaceutical Co Ltd (NYSE:TAK) » Definitions » Other Stockholders Equity

Comparable Companies

Traded in Other Exchanges

TKPHF:USA TAK:Mexico 4502:Japan 4502:Japan 4502:Japan 4502:Japan TKDA:Germany TKD:Germany TKD:Germany TAKP34:Brazil

Address

1-1, Nihonbashi-Honcho 2-Chome, Chuo-ku, Tokyo, JPN, 103-8668

Website

https://www.takeda.com

Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4 trillion in fiscal 2022. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with 50% derived from the U.S., 20% from Japan, 20% from Europe and Canada.